In vitro and in vivo evaluation of three metronidazole topical products

References

• Shah VP. IV-IVC for topically applied preparations – a critical evaluation. Eur J Pharm Biopharm 2005;60:309–14
   PubMed Web of Science ®Google Scholar
• Shah VP, Flynn GL, Yacobi A, et al. Bioequivalence of topical dermatological dosage forms-methods of evaluation of bioequivalence. Pharm Res 1998;15:167–71
   PubMed Web of Science ®Google Scholar
• Garcia Ortiz P, Hansen SH, Shah VP, et al. Are marketed topical metronidazole creams bioequivalent? Evaluation by in vivo microdialysis sampling and tape stripping methodology. Skin Pharmacol Physiol 2011;24:44–53
   PubMed Web of Science ®Google Scholar
• Benfeldt E, Hansen SH, Volund A, et al. Bioequivalence of topical formulations in humans: evaluation by dermal microdialysis sampling and the dermatopharmacokinetic method. J Invest Dermatol 2007;127:170–8
   PubMed Web of Science ®Google Scholar
• Herkenne C, Naik A, Kalia YN, et al. Effect of propylene glycol on ibuprofen absorption into human skin in vivo. J Pharm Sci 2008;97:185–97
   PubMed Web of Science ®Google Scholar
• Chaurasia CS, Muller M, Bashaw ED, et al. AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives. Pharm Res 2007;24:1014–25
   PubMed Web of Science ®Google Scholar
• Holmgaard R, Nielsen JB, Benfeldt E. Microdialysis sampling for investigations of bioavailability and bioequivalence of topically administered drugs: current state and future perspectives. Skin Pharmacol Physiol 2010;23:225–43
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration, Center for Drug Evaluation and Research – Guidance for Industry: Nonsterile Semisolid Dosage Forms. Scale-up and postapproval changes: chemistry, manufacturing, and controls; in vitro release testing and in vivo bioequivalence documentation; 1997
   Google Scholar
• US Food and Drug Administration, Center for Drug Evaluation and Research – Draft Guidance on Acyclovir. 2012. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM296733.pdf [last accessed on 12 Nov 2012]
   Google Scholar
• Hadgraft J, Whitefield M, Rosher PH. Skin penetration of topical formulations of ibuprofen 5%: an in vitro comparative study. Skin Pharmacol Appl Skin Physiol 2003;16:137–42
   PubMedGoogle Scholar
• Brain KR, Green DM, Dykes PJ, et al. The role of menthol in skin penetration from topical formulations of ibuprofen 5% in vivo. Skin Pharmacol Physiol 2006;19:17–21
   PubMed Web of Science ®Google Scholar
• Moser K, Kriwet K, Naik A, et al. Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm 2001;52:103–12
   PubMed Web of Science ®Google Scholar
• Walker RB, Smith EW. The role of percutaneous penetration enhancers. Adv Drug Deliver Rev 1996;18:295–301
   Web of Science ®Google Scholar
• Weigmann HJ, Lademann J, Schanzer S, et al. Correlation of the local distribution of topically applied substances inside the stratum corneum determined by tape-stripping to differences in bioavailability. Skin Pharmacol Physiol 2001;14:98–102
   Google Scholar
• Kryscio D, Sathe P, Lionberger R, et al. Spreadability measurements to assess structural equivalence (Q3) of topical formulations – a technical note. AAPS PharmSciTech 2008;9:84–6
   PubMedGoogle Scholar
• Ueda CT, Shah VP, Derdzinski K, et al. Topical and transdermal drug products. Dissolut Technol 2010;17:12–25
   Web of Science ®Google Scholar
• Wagner N, Berthaud C, Laffet G, et al. Differential penetration of skin by topical metronidazole formulations. Adv Ther 1998;15:197–205
   PubMedGoogle Scholar
• Draelos ZD. Assessment of skin barrier function in rosacea patients with a novel 1% metronidazole gel. J Drugs Dermatol. 2005;4:557–62
   PubMedGoogle Scholar
• Elewski BE. Percutaneous absorption kinetics of topical metronidazole formulations in vitro in the human cadaver skin model. Adv Ther 2007;24:239–46
   PubMed Web of Science ®Google Scholar
• Yoo J, Reid DC, Kimball AB. Metronidazole in the treatment of rosacea: do formulation, dosing, and concentration matter? J Drugs Dermatol 2006;5:317–19
   PubMedGoogle Scholar
• Miron DS, Radulescu FS, Voicu VA, et al. Diffusion and rheological evaluations as valuable quality control, in-vivo performance predictive tools for topical drug products. Farmacia 2010;58:485–93
   Google Scholar
• Flynn G, Shah V, Tenjarla S, et al. Assessment of value and applications of in vitro testing of topical dermatological drug products. Pharm Res 1999;16:1325–30
   PubMed Web of Science ®Google Scholar
• Malzfeldt E, Lehmann P, Goerz G, et al. Influence of drug solubility in the vehicle on clinical efficacy of ointments. Arch Dermatol Res 1989;281:193–7
   PubMed Web of Science ®Google Scholar
• Møllgaard B, Hoelgaard A. Permeation of estradiol through the skin – effect of vehicles. Int J Pharm 1983;15:185–97
   Google Scholar
• Dreher F, Walde P, Walther P, et al. Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport. J Control Release 1997;45:131–40
   Web of Science ®Google Scholar
• Guo H, Liu Z, Li J, et al. Effects of isopropyl palmitate on the skin permeation of drugs. Biol Pharm Bull 2006;29:2324–6
   PubMed Web of Science ®Google Scholar